These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21995575)

  • 61. Tumor-Stromal Cell Communication: Small Vesicles Signal Big Changes.
    Wendler F; Stamp GW; Giamas G
    Trends Cancer; 2016 Jul; 2(7):326-329. PubMed ID: 28741534
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fibroblast independency in tumors: implications in cancer therapy.
    Tsellou E; Kiaris H
    Future Oncol; 2008 Jun; 4(3):427-32. PubMed ID: 18518767
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor-induced perturbations of cytokines and immune cell networks.
    Burkholder B; Huang RY; Burgess R; Luo S; Jones VS; Zhang W; Lv ZQ; Gao CY; Wang BL; Zhang YM; Huang RP
    Biochim Biophys Acta; 2014 Apr; 1845(2):182-201. PubMed ID: 24440852
    [TBL] [Abstract][Full Text] [Related]  

  • 64. More than a scaffold: Stromal modulation of tumor immunity.
    Johansson A; Hamzah J; Ganss R
    Biochim Biophys Acta; 2016 Jan; 1865(1):3-13. PubMed ID: 26071879
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy.
    Di Martino MT; Zazzeroni F; Donadelli M; Chiodoni C; Caraglia M; Scotlandi K; Meschini S; Leonetti C
    J Exp Clin Cancer Res; 2018 Mar; 37(1):48. PubMed ID: 29506548
    [No Abstract]   [Full Text] [Related]  

  • 66. Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment.
    Young EW
    Integr Biol (Camb); 2013 Sep; 5(9):1096-109. PubMed ID: 23799587
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multifaceted kinetics of immuno-evasion from tumor dormancy.
    d'Onofrio A
    Adv Exp Med Biol; 2013; 734():111-43. PubMed ID: 23143978
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The tumour microenvironment as an integrated framework to understand cancer biology.
    Burgos-Panadero R; Lucantoni F; Gamero-Sandemetrio E; Cruz-Merino L; Álvaro T; Noguera R
    Cancer Lett; 2019 Oct; 461():112-122. PubMed ID: 31325528
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genetic instability in the tumor microenvironment: a new look at an old neighbor.
    Palumbo A; Da Costa Nde O; Bonamino MH; Pinto LF; Nasciutti LE
    Mol Cancer; 2015 Jul; 14():145. PubMed ID: 26227631
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeting the Tumor Microenvironment in Radiation Oncology: Proceedings from the 2018 ASTRO-AACR Research Workshop.
    McGee HM; Jiang D; Soto-Pantoja DR; Nevler A; Giaccia AJ; Woodward WA
    Clin Cancer Res; 2019 May; 25(10):2969-2974. PubMed ID: 30723144
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Targeting the tumor microenvironment for cancer therapy.
    Sounni NE; Noel A
    Clin Chem; 2013 Jan; 59(1):85-93. PubMed ID: 23193058
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Missed Druggable Cancer Hallmark: Cancer-Stroma Symbiotic Crosstalk as Paradigm and Hypothesis for Cancer Therapy.
    Sverdlov E
    Bioessays; 2018 Nov; 40(11):e1800079. PubMed ID: 30188575
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stromal cell-based immunotherapy in transplantation.
    Charles R; Lu L; Qian S; Fung JJ
    Immunotherapy; 2011 Dec; 3(12):1471-85. PubMed ID: 22091683
    [TBL] [Abstract][Full Text] [Related]  

  • 74. PET imaging of the immune system: immune monitoring at the whole body level.
    Singh AS; Radu CG; Ribas A
    Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):281-90. PubMed ID: 20639814
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Non-hematopoietic Control of Peripheral Tissue T Cell Responses: Implications for Solid Tumors.
    Lane RS; Lund AW
    Front Immunol; 2018; 9():2662. PubMed ID: 30498499
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The enduring neutrophil-stroma dance of multiple myeloma.
    Cerezo-Wallis D; Ballesteros I
    Nat Immunol; 2024 May; 25(5):731-732. PubMed ID: 38600357
    [No Abstract]   [Full Text] [Related]  

  • 77. The solid tumor microenvironment-Breaking the barrier for T cells: How the solid tumor microenvironment influences T cells: How the solid tumor microenvironment influences T cells.
    Simsek H; Klotzsch E
    Bioessays; 2022 Jun; 44(6):e2100285. PubMed ID: 35393714
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lymph Node Stroma Dynamics and Approaches for Their Visualization.
    Gentek R; Bajénoff M
    Trends Immunol; 2017 Apr; 38(4):236-247. PubMed ID: 28214099
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tumor stroma as a target in cancer.
    Ahmed F; Steele JC; Herbert JM; Steven NM; Bicknell R
    Curr Cancer Drug Targets; 2008 Sep; 8(6):447-53. PubMed ID: 18781891
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Introduction to tumor-stroma interactions.
    Ostman A; Pietras K
    Exp Cell Res; 2013 Jul; 319(11):1595. PubMed ID: 25242505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.